Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.


Ndembi, N; Ndembi, N; Goodall, RL; Dunn, DT; McCormick, A; Burke, A; Lyagoba, F; Munderi, P; Katundu, P; Kityo, C; Robertson, V; Yirrell, DL; Walker, AS; Gibb, DM; Gilks, CF; Kaleebu, P; Pillay, D; Development of Antiretroviral Treatment in Africa Virology Group, H; ], ; (2010) Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir. The Journal of infectious diseases, 201 (1). pp. 106-13. ISSN 0022-1899 DOI: https://doi.org/10.1086/648590

Full text not available from this repository.

Abstract

We investigated virological response and the emergence of resistance in the Nevirapine or Abacavir (NORA) substudy of the Development of Antiretroviral Treatment in Africa (DART) trial.

Item Type: Article
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology
Research Centre: Centre for Global Non-Communicable Diseases (NCDs)
Tropical Epidemiology Group
PubMed ID: 19938977
Web of Science ID: 273078000014
URI: http://researchonline.lshtm.ac.uk/id/eprint/18676

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
274Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item